A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD
Public ClinicalTrials.gov record NCT02038829. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD: GOLDEN 6 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Study for subjects 40 to 65 years-old with a diagnosis of moderate to severe COPD. Aclidinium bromide 400 mcg 2x a day will be given as an active comparator.
Study identification
- NCT ID
- NCT02038829
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 96 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- SUN101 3 mcg Drug
- SUN-101 6.25 mcg Drug
- SUN-101 12.5 mcg Drug
- SUN-101 50 mcg Drug
- Aclidinium Drug
Drug
Eligibility (public fields only)
- Age range
- 40 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2013
- Primary completion
- Apr 30, 2014
- Completion
- Apr 30, 2014
- Last update posted
- Apr 9, 2018
2014
United States locations
- U.S. sites
- 10
- U.S. states
- 4
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Research of West Florida, Inc. | Clearwater | Florida | 33765 | — |
| American Health Research, Inc. | Charlotte | North Carolina | 28207 | — |
| North Carolina Clinical Research | Raleigh | North Carolina | 27607 | — |
| Clinical Research Institute of Southern Oregon, PC | Medford | Oregon | 97504 | — |
| Palmetto Medical Research Associates, LLC | Easley | South Carolina | 29640 | — |
| Greenville Pharmaceutical Research, Inc. | Greenville | South Carolina | 29615 | — |
| Upstate Pharmaceutical Research | Greenville | South Carolina | 29615 | — |
| S. Carolina | Spartanburg | South Carolina | 29303 | — |
| Spartanburg Medical Research | Spartanburg | South Carolina | 29303 | — |
| CU Pharmaceutical Research | Union | South Carolina | 29379 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02038829, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 9, 2018 · Synced Sep 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02038829 live on ClinicalTrials.gov.